期刊文献+

氨基末端钠尿肽前体对预测直接介入治疗急性ST段抬高心肌梗死患者预后的价值 被引量:1

Effect of N-terminal pro-brain natriuretic peptide on prognosis of patients with acute STEMI after primary PCI
在线阅读 下载PDF
导出
摘要 目的评价氨基末端钠尿肽前体(NT-proBNP)对接受直接PCI的急性ST段抬高心肌梗死(STEMI)患者远期预后价值。方法顺序入选2008年12月~2010年6月胸痛发作<12 h并接受直接PCI的STEMI住院患者125例,根据随访期内有无心血管事件,分为事件组22例和非事件组103例,入院后12 h内测定NT-proBNP水平,随访1年内心血管事件的发生情况,并进行相关分析。结果与非事件组比较,事件组的NT-proBNP水平显著增高(P<0.05);在预测1年心血管事件中NT-proBNP的ROC曲线下面积为0.778。NT-proBNP阈值为729pmol/L时,Kaplan-Meier生存分析显示,NT-proBNP≤729 pmol/L患者1年无心血管事件生存率显著高于NT-proBNP>729 pmol/L者(P<0.01)。多元Cox回归分析显示,NT-proBNP、LVEF、肌钙蛋白Ⅰ峰值是患者远期发生心血管事件的独立预测因素。结论 NT-proBNP可以预测接受直接PCI急性STEMI患者的远期预后。 Objective To assess the long-term effect of N-terminal pro-brain natriuretic peptide (NT-proBNP) on prognosis of patients with ST elevation myocardial infaretion(STEMI) after primary PCI. Methods One hundred and twenty-five STEMI patients with chest pain who under- went PCI within 12 h after admission from December 2008 to June 2010 were divided into cardiac event group(n: 22) and non cardiac event group (n = 103) according to the occurrence of cardiac events during follow-up. NT-proBNP level was measured within 12 h after admission. The pa- tients were followed up for 1 year,during which the incidence of cardiac events was observed. Re- sults The NT-proBNP level was significantly higher in cardiac event group than in non cardiac event group(P〈0.05). The area under ROC curves for NT-proBNP was 0. 778. Kaplan-Meier analysis showed that the 1-year survival rate was significantly higher in free cardiac event patients with their NT-proBNP level ≤729 pmol/L than in those with their NT-proBNP level 〉 729 pmol/L(P〈0.01). Cox regression analysis showed that the peak NT-proBNP, LVEF and cTnI values were the independent predicting factors for the long-term outcomes of cardiovascular events in acute STEMI patients after primary PCI. Conclusion NT-proBNP can predict the long- term outcomes in acute STEMI patients after primary PCI.
出处 《中华老年心脑血管病杂志》 CAS 北大核心 2012年第9期907-910,共4页 Chinese Journal of Geriatric Heart,Brain and Vessel Diseases
关键词 心肌梗死 利钠肽 急性冠状动脉综合征 阿司匹林 肌钙蛋白I ROC曲线 预后 myocardial infarction natriuretic peptide, brain acute coronary syndrome aspirin tro-ponin I ROC curve prognosis
  • 相关文献

参考文献9

  • 1Galvani M,Ottani F,Oltrona L,et al. N-terminal pro-brain na- triuretie peptide on admission has prognostic value across the whole spectrum of acute coronary syndromes. Circulation, 2004,110.128-134.
  • 2Anderson JL, Adams CD, Antma EM, et al. ACC/AHA guide- lines for the management o{ patients with unstable angina and non-ST segment elevation myocardial infarction: A report of the American College of Cardiology/American Heart Associa- tion Task Force on practice guidelines (Committee on the Man agement of Patients with Unstable Angina). ] Am Coil Cardi ol,2007,14:e1-e157.
  • 3Lorgis L,Cottin Y,Danchin N,et al. Impact of obesity on the prognostic value of the N-terminal pro-B-type natriuretic pep- tide (NT-proBNP) in patients with acute myocardial infarc- tion. Heart, 2011,97 : e551-e556.
  • 4Choi SG,Jeong MH, Ahn Y. Relationship between obesity and N-terminal brain natriuretie peptide level as a prognostic value after acute myocardial infarction. Korean Cire J, 2010,40 : 558 564.
  • 5Martinez-Rumayor A, Richards AM, Burnett JC, et al. Biology of the natriuretic peptides. Am J Cardiol, 2008,101 : 3-8.
  • 6严山,刘雅,刘洁琳,楼煜清,刘阔,文杰,朱小玲,李志忠,温绍君.血浆氨基末端脑钠肽前体水平评价冠心病严重程度的价值[J].中华老年心脑血管病杂志,2009,11(11):834-836. 被引量:3
  • 7严山,刘洁琳,刘雅,王佐广,文杰,楼煜清,刘阔,李志忠,温绍君.氨基末端脑钠肽前体对不稳定型心绞痛和(或)非ST段抬高心肌梗死患者冠状动脉病变程度的预测[J].心肺血管病杂志,2009,28(5):307-310. 被引量:21
  • 8衣志勇,李小鹰,蒋知新,孙玉发,查政,刘亚巍,袁凤仪,袁向珍,李庆勇.N末端原脑钠肽对急性冠状动脉综合征患者远期预后的预测价值[J].中华老年医学杂志,2011,30(2):109-113. 被引量:10
  • 9Collinson PO, Gaze DC. Biomarkers of cardiovascular damage and dysfunction. An overview. Heart Lung Circ, 2007,16 ; $71- $82.

二级参考文献34

  • 1韦铁民,曾春来,陈礼平,陈群英,赵瑞英,吕干新,吕玲春.不同类型心力衰竭血浆B型尿钠肽浓度比较[J].心肺血管病杂志,2004,23(3):135-138. 被引量:5
  • 2曹雅旻,胡大一,闫丽.急性冠状动脉综合征严重程度与血浆氨基酸N末端脑钠肽原浓度相关性的研究[J].中华心血管病杂志,2005,33(10):899-902. 被引量:60
  • 3邴紫伊,朱平,陈晓平.脑钠肽前体N末端片断检测对急性冠状动脉综合征的临床价值[J].中华老年心脑血管病杂志,2006,8(9):641-642. 被引量:2
  • 4Christmas MA M, Tobias B, Kirsten L, et al.Comparison of the diagnostic accuracy of brain natriuretic peptide (BNP) and the N-Terminal part of the propeptide of BNP immunoassays in chronic and acute heart failure: A Systematic Review. Clinical Chemistry, 2007,53 : 813-822.
  • 5Weber M, Bazzino O, Jose L, et al. Terminal B-type natriuretic Peptide assessment provides incremental prognostic information in patients with acute coronary syndromes and normal troponin T values upon admission. J Am Coll Cardiol, 2008,51:1188-1195.
  • 6Grabowski M, Filipiak K J, Malek LA. Admission B-type natriuretie peptide assessment improves early risk stratification by Killip classes and TIMI risk score in patients with acute ST elevation myocardial infarction treated with primary angioplasty. Int J Cardiol,2007.115 : 386-390.
  • 7Estrada JLN, Rubinstein F, Bahit MC et al. NT-probrain natriuretic peptide predicts complexity and severity of the coronary lesions in patients with non-ST-elevation acute coronary syndromes. Am Heart J, 2006, 151:1093 -1093.
  • 8Daniel S, Charly N, Michael J, et al. Use of B-type natriuretic peptide in the detection of myocardial ischemia. Am Heart J, 2006, 151 : 1223-1230.
  • 9Goetze J, Gore A, Christian H, et al. Acute myocardial hypoxia increases BNP gene expression. The FASEB Journal, 2004,10:1096-1106.
  • 10Sabatine M S, Morrow D A, Delemos J A, et al. Acute changes in circulating Natriuretic peptide levels in relation to myocardial ischemia. J Am Coll Cardiology, 2004, 40: 1988-1995.

共引文献30

同被引文献12

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部